Lodo Therapeutics
Christine Gorjanc provides extensive financial, operational and technology experience to guide Zymergen’s growth. She previously served as the CFO of home automation company, Arlo Technologies, Inc., and CFO of NETGEAR, Inc. and currently sits on the boards at networking and cybersecurity solutions company Juniper Networks and genetic information company Invitae Corporation. She earned a B.A. in accounting with honors from the University of Texas at El Paso and an M.S. in taxation from Golden Gate University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lodo Therapeutics
1 followers
Lodo Therapeutics discovers and develops novel therapeutics addressing "undruggable" targets with high unmet need by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA.